サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：動物用ワクチンの世界市場（2023年）
市場調査レポート
商品コード
1194104

動物用ワクチンの世界市場（2023年）

Veterinary Vaccines
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 263 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
動物用ワクチンの世界市場（2023年）
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 263 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の動物用ワクチンの市場規模は、2022年の83億米ドルから、2030年には131億米ドルに達し、2022年～2030年の分析期間にかけて5.9％のCAGRで成長すると予測されています。

当レポートでは、世界の動物用ワクチン市場について調査分析し、市場動向と促進要因、見通し、地域分析、競合情勢などの情報を提供しています。

調査対象企業の例（全22社）：

  • Bayer de Mexico SA de CV
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health
  • Heska Corporation
  • Indian Immunologicals Ltd.
  • Merck Animal Health
  • Virbac SA
  • Zoetis Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋地域
  • その他の地域

第4章 競合

目次
Product Code: MCP-1129

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Veterinary Vaccines Market to Reach $13.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Veterinary Vaccines estimated at US$8.3 Billion in the year 2022, is projected to reach a revised size of US$13.1 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2022-2030. Porcine Vaccines, one of the segments analyzed in the report, is projected to record a 6.9% CAGR and reach US$4.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Poultry Vaccines segment is readjusted to a revised 6.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.4 Billion, While China is Forecast to Grow at 5.4% CAGR

The Veterinary Vaccines market in the U.S. is estimated at US$2.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 5.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 22 Featured):

  • Bayer de Mexico SA de CV
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health
  • Heska Corporation
  • Indian Immunologicals Ltd.
  • Merck Animal Health
  • Virbac SA
  • Zoetis Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Recent Market Activity
    • Market Outlook
    • Important Animal Diseases
    • Veterinary Vaccines Market on a Growth Trajectory
    • Livestock Vaccines Rule the Roost
    • Select Animal Disease Vaccines
    • Mature Markets Vis-a-vis Emerging Markets
    • Veterinary Vaccines Market based on Technology
    • Live Attenuated Vaccines
    • Killed/Inactivated Vaccines
    • Recombinant vector vaccines
    • Recombinant DNA Technology to Take Over the Industry
    • Vector-based Vaccines
    • DNA Vaccines
    • Subunit and Virus-Like Particle (VLP)-based vaccines
    • Targeted Deletions/Modifications-based Vaccines
    • Collaborative R&D for Various Types of Veterinary Vaccines
    • Market Challenges
    • Veterinary Vaccines - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • Bayer AG (Germany)
    • Biogenesis Bago SA (Argentina)
    • Boehringer Ingelheim International GmbH (Germany)
    • Ceva Sante Animale (France)
    • Elanco Animal Health (USA)
    • Diamond Animal Health (USA)
    • Indian Immunologicals Ltd. (India)
    • Merck Animal Health (USA)
    • Virbac SA (France)
    • Zoetis Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Need to Ensure Sustainable Food Supply Spurs Growth
    • Increasing Demand for Animal Protein in Developing Countries to Benefit the Market
    • Increasing Pet Ownership Drives Demand for Companion Animal Vaccines
    • Spread of Zoonotic Diseases Propels Growth of Veterinary Vaccines
    • Social Concerns on Slaughtering Presents a Valid Case for Use of Vaccines
    • Novel Trends in Animal Vaccine Development
    • Reduced Response Time
    • Drug Resistance
    • Serotype Cross-Protection
    • Innovative Manufacturing
    • Technological Advancements
    • Porcine Market Offers Significant Prospects for Growth and New Vaccine Development
    • Select Swine Diseases
    • Select Key Marketed Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccines
    • Porcine Epidemic Diarrhea Virus (PEDV) Vaccines Available in Select Countries
    • Improvised Adjuvant Usage and Veterinary Vaccine Delivery Systems
    • Anthrax and Other Vaccines with Improved Adjuvants in the Pipeline
    • Matrix™ Adjuvant Technology by Novavax
    • Global Efforts to Conquer FMD by an Effective Vaccine
    • Member Countries with Endorsed Official Control Programme for FMD
    • FMD Free Zone Where Vaccination Is Practised
    • Foot-and-Mouth Disease Vaccines Available
    • Developments in the Poultry Vaccine Market
    • Vaccination - Critical for Controlling Avian Influenza Virus
    • Avian Influenza Vaccines
    • New Effervescent Tablets Vaccines against NDV - Augmenting Trend towards Convenient Administration
    • Vaccination in the Hatchery Gains Momentum
    • Parasitic Vaccines Segment Holds Potential
    • Egg-Derived Veterinary Vaccines in Human Vaccine Facilities
    • New Vaccine Strains - The Imminent Need in the Vaccine Market
    • The Need for Innovative Vaccine Delivery Mechanism Increasing
    • More Vaccines Needed to Prevent Zoonotic Infections
    • Plant-based Vaccines - the Next Avenue in Cost - effective and Efficacious Vaccines; Obstacles Persist Delaying Market Debut
    • Pricing Affects the Livestock Vaccine Market
    • Over-Vaccination Trend May Prove Harmful
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Veterinary Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Porcine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Porcine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Poultry Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Canine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Canine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Bovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Bovine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Feline Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Ovine Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Ovine Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Inactivated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Inactivated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Live Attenuated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Live Attenuated Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Live Attenuated Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Recombinant Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Recombinant Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Recombinant Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Toxoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Toxoid Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Toxoid Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Other Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 39: World 16-Year Perspective for Other Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 40: World Veterinary Vaccines Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • JAPAN
    • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • CHINA
    • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: China 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • EUROPE
    • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • FRANCE
    • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: France 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: France 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • GERMANY
    • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Veterinary Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Veterinary Vaccines by Type - Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Rest of World 16-Year Perspective for Veterinary Vaccines by Type - Percentage Breakdown of Value Sales for Porcine Vaccines, Poultry Vaccines, Canine Vaccines, Bovine Vaccines, Feline Vaccines, Ovine Vaccines and Other Types for the Years 2014, 2023 & 2030
    • TABLE 113: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Rest of World Historic Review for Veterinary Vaccines by Technology - Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Rest of World 16-Year Perspective for Veterinary Vaccines by Technology - Percentage Breakdown of Value Sales for Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines and Other Vaccines for the Years 2014, 2023 & 2030

IV. COMPETITION